Notice2022-20843
National Cancer Institute; Notice of Closed Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 27, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 186 (Tuesday, September 27, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 186 (Tuesday, September 27, 2022)]
[Notices]
[Pages 58504-58505]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-20843]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Board of Scientific
Counselors, National Cancer Institute.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in sections 552b(c)(6), Title
5 U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Cancer Institute, including consideration of personnel qualifications
and performance, and the competence of individual investigators, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Board of Scientific Counselors, National
Cancer Institute.
Date: November 7-8, 2022.
Time: 11:00 a.m. to 3:10 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Place: National Cancer Institute, 9609 Medical Center Drive,
Rockville, MD 20850 (Virtual Meeting).
Contact Person: Brian E. Wojcik, Ph.D., Senior Review
Administrator, Institute Review Office, Office of the Director,
National Cancer Institute, National Institutes of Health, 9609
Medical Center Drive, Room 3W414, Rockville, MD 20850, 240-276-5660,
<a href="/cdn-cgi/l/email-protection#15627a7f767c7e775578747c793b7b7c7d3b727a63"><span class="__cf_email__" data-cfemail="0e7961646d67656c4e636f67622060676620696178">[email protected]</span></a>.
Information is also available on the Institute's/Center's home
page: <a href="https://deainfo.nci.nih.gov/advisory/bsc/index.htm">https://deainfo.nci.nih.gov/advisory/bsc/index.htm</a>, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction;
[[Page 58505]]
93.393, Cancer Cause and Prevention Research; 93.394, Cancer
Detection and Diagnosis Research; 93.395, Cancer Treatment Research;
93.396, Cancer Biology Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399, Cancer Control, National
Institutes of Health, HHS)
Dated: September 21, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-20843 Filed 9-26-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 27, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.